BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 22, 2019
View Archived Issues
Corralling cellular culprits in autism
Read More
Universal editing approach to hemophilia A
Read More
A new mouse model of the parasitic helminth Loa loa
Read More
Umeclidinium is effective and well tolerated in phase II asthma trial
Read More
Phase IIa data presented for ANB-020 in patients with peanut allergy
Read More
RPRML acts as tumor suppressor and is a potential new biomarker in gastric cancer
Read More
Celgene presents results from phase I APHRODITE study of CC-11050
Read More
EXOSC5 as a novel prognostic marker in gastric cancer
Read More
Plaque transcriptomic analysis provides insights into Peyronie's disease
Read More
New treatment approach developed for allergic asthma
Read More
L-MIND study of tafasitamab and lenalidomide in DLBCL meets primary endpoint
Read More
MicroRNA 597-5p involved in invasion and metastasis in gastric cancer
Read More
FDA clears Abeona's IND for phase I/II study of gene therapy ABO-202 for CLN1 disease
Read More
Phase III BEACON CRC study of Braftovi triplet therapy meets primary endpoints
Read More
Santhera, University of Basel to work together on gene therapy research for LAMA2 MD
Read More
Crinetics begins phase I study of CRN-01941 for neuroendocrine tumors
Read More
Allergy Therapeutics reports topline results from phase I study of Acarovac MPL
Read More
ABI-009, an mTOR inhibitor, shows promise for treating PAH
Read More
JCR initiates phase I trial of long-acting growth hormone JR-142
Read More
Valneva reports new data from ongoing phase I study of chikungunya vaccine candidate VLA-1553
Read More
Bayer presents compounds for cardiovascular diseases
Read More
Toray Industries divulges RORC antagonists
Read More
Medshine Discovery synthesizes new Wee1 inhibitors
Read More
Novartis describes new KCNH2 activators
Read More
Debiopharm initiates exploratory study of Debio-1143 with nivolumab in advanced solid tumors
Read More
Oncostellae presents androgen and glucocorticoid receptor antagonists
Read More
IMDB recommends continuation of phase III trial of Toca-511/Toca-FC in high-grade glioma
Read More